NASDAQ: EKSO - Ekso Bionics Holdings, Inc.

Yield per half year: -61.46%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Ekso Bionics Holdings, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Ekso Bionics Holdings, Inc.

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.

more details
The company also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therap, an adjustable and lower-limb powered exoskeleton; and Ekso Indego Personal, a powered lower limb orthosis. It has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in San Rafael, California.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2014-01-16
ISIN US2826443010
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.eksobionics.com
Цена ао 0.449
Change price per day: -0.0252% (0.3971)
Change price per week: -0.0504% (0.3972)
Change price per month: -7.91% (0.4311)
Change price per 3 month: -38.93% (0.6501)
Change price per half year: -61.46% (1.03)
Change price per year: -68.98% (1.28)
Change price per 3 year: -85.72% (2.78)
Change price per 5 year: +78.83% (0.222)
Change price per year to date: -34.92% (0.61)
All parameters

Underestimation

Title Value Grade
P/S 1.28 9
P/BV 1.86 8
P/E 0 0
EV/EBITDA -1.64 0
Total: 5.88

Efficiency

Title Value Grade
ROA, % -52.56 0
ROE, % -120.56 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.4805 10
Total: 9.6

Growth impulse

Title Value Grade
Yield Revenue, % 31.5 5
Yield Ebitda, % -26.27 0
Yield EPS, % -55.08 0
Total: 1.8
More

Institutions Volume Share, %
Vanguard Group Inc 436925 2.44
Essex Investment Management Co LLC 157655 0.88
Kent Lake Capital, LLC 141158 0.79
Geode Capital Management, LLC 98455 0.55
Renaissance Technologies, LLC 80016 0.45
Blackrock Inc. 55453 0.31
Strategic Wealth Investment Group, LLC 51950 0.29
Compagnie Lombard Odier SCmA 25000 0.14
Northern Trust Corporation 24959 0.14
State Street Corporation 23180 0.13



Head Job title Payment Year of birth
Mr. Scott G. Davis CEO & Director 637.02k 1970 (55 years)
Mr. Jerome Wong Chief Financial Officer 491.39k 1974 (51 year)
Mr. Jason C. Jones Chief Operating Officer 447.42k
Ms. Rachael Anderson Global Director of Marketing & Strategic Growth N/A
Ms. Ann Cookson Human Resources Director N/A
Ms. Foon Lim Chwee President of APAC N/A
Mr. Stephan Aderhold Senior VP & GM of EMEA N/A

Address: United States, San Rafael. CA, 101 Glacier Point - open in Google maps, open in Yandex maps
Website: https://www.eksobionics.com